Optimaliseren van het antibioticabeleid in Nederland. XII. SWAB-richtlijn voor de behandeling van MRSA-dragerschap

H. F.L. Wertheim; H. S.M. Ammerlaan; M. J.M. Bonten; P. J. Van Den Broek; A. Troelstra; C. M.J.E. Vandenbroucke-Grauls; M. C. Vos; A. Voss; J. L. Nouwen; J. A.J.W. Kluytmans

Optimaliseren van het antibioticabeleid in Nederland. XII. SWAB-richtlijn voor de behandeling van MRSA-dragerschap

Translated title of the contribution: Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers

H. F.L. Wertheim, H. S.M. Ammerlaan, M. J.M. Bonten, P. J. Van Den Broek, A. Troelstra, C. M.J.E. Vandenbroucke-Grauls, M. C. Vos, A. Voss, J. L. Nouwen, J. A.J.W. Kluytmans

Research output: Contribution to journal › Review article › peer-review

15 Citations (Scopus)

Abstract

- The 'Stichting Werkgroep Antibioticabeleid' (SWAB; Dutch Working Party on Antibiotics Policy) has developed evidence-based guidelines for the antimicrobial treatment of methicillin-resistant Staphylococcus aureus (MRSA) carriers for the eradication of MRSA. - A distinction was made between uncomplicated and complicated carriage depending on the presence or absence of an active MRSA infection, skin lesions, foreign body material, mupirocin resistance and/or extranasal carriage. - The indication for treatment is determined by the consequences of carriage for the carrier and his/her environment, the adverse events of treatment, and the likelihood of a successful treatment. - The first choice of treatment in uncomplicated carriers is a combination of mupirocin nasal ointment and disinfectant soap for 5 days, along with hygiene advice. - If treatment fails, sources in the vicinity of the patient must be sought. - Complicated carriers receive a combination of 2 oral antibiotics, in addition to mupirocin nasal ointment and disinfectant soap, for at least 7 days.

Translated title of the contribution	Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers
Original language	Dutch
Pages (from-to)	2667-2671
Number of pages	5
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	152
Issue number	49
Publication status	Published - 6 Dec 2008

Cite this

Wertheim, H. F. L., Ammerlaan, H. S. M., Bonten, M. J. M., Van Den Broek, P. J., Troelstra, A., Vandenbroucke-Grauls, C. M. J. E., Vos, M. C., Voss, A., Nouwen, J. L., & Kluytmans, J. A. J. W. (2008). Optimaliseren van het antibioticabeleid in Nederland. XII. SWAB-richtlijn voor de behandeling van MRSA-dragerschap. Nederlands Tijdschrift voor Geneeskunde, 152(49), 2667-2671.

@article{3b5cccd23a1441b38254ccc4f1c1de03,

title = "Optimaliseren van het antibioticabeleid in Nederland. XII. SWAB-richtlijn voor de behandeling van MRSA-dragerschap",

abstract = "- The 'Stichting Werkgroep Antibioticabeleid' (SWAB; Dutch Working Party on Antibiotics Policy) has developed evidence-based guidelines for the antimicrobial treatment of methicillin-resistant Staphylococcus aureus (MRSA) carriers for the eradication of MRSA. - A distinction was made between uncomplicated and complicated carriage depending on the presence or absence of an active MRSA infection, skin lesions, foreign body material, mupirocin resistance and/or extranasal carriage. - The indication for treatment is determined by the consequences of carriage for the carrier and his/her environment, the adverse events of treatment, and the likelihood of a successful treatment. - The first choice of treatment in uncomplicated carriers is a combination of mupirocin nasal ointment and disinfectant soap for 5 days, along with hygiene advice. - If treatment fails, sources in the vicinity of the patient must be sought. - Complicated carriers receive a combination of 2 oral antibiotics, in addition to mupirocin nasal ointment and disinfectant soap, for at least 7 days.",

author = "Wertheim, {H. F.L.} and Ammerlaan, {H. S.M.} and Bonten, {M. J.M.} and {Van Den Broek}, {P. J.} and A. Troelstra and Vandenbroucke-Grauls, {C. M.J.E.} and Vos, {M. C.} and A. Voss and Nouwen, {J. L.} and Kluytmans, {J. A.J.W.}",

year = "2008",

month = dec,

day = "6",

language = "Dutch",

volume = "152",

pages = "2667--2671",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu van Loghum",

number = "49",

}

TY - JOUR

T1 - Optimaliseren van het antibioticabeleid in Nederland. XII. SWAB-richtlijn voor de behandeling van MRSA-dragerschap

AU - Wertheim, H. F.L.

AU - Ammerlaan, H. S.M.

AU - Bonten, M. J.M.

AU - Van Den Broek, P. J.

AU - Troelstra, A.

AU - Vandenbroucke-Grauls, C. M.J.E.

AU - Vos, M. C.

AU - Voss, A.

AU - Nouwen, J. L.

AU - Kluytmans, J. A.J.W.

PY - 2008/12/6

Y1 - 2008/12/6

N2 - - The 'Stichting Werkgroep Antibioticabeleid' (SWAB; Dutch Working Party on Antibiotics Policy) has developed evidence-based guidelines for the antimicrobial treatment of methicillin-resistant Staphylococcus aureus (MRSA) carriers for the eradication of MRSA. - A distinction was made between uncomplicated and complicated carriage depending on the presence or absence of an active MRSA infection, skin lesions, foreign body material, mupirocin resistance and/or extranasal carriage. - The indication for treatment is determined by the consequences of carriage for the carrier and his/her environment, the adverse events of treatment, and the likelihood of a successful treatment. - The first choice of treatment in uncomplicated carriers is a combination of mupirocin nasal ointment and disinfectant soap for 5 days, along with hygiene advice. - If treatment fails, sources in the vicinity of the patient must be sought. - Complicated carriers receive a combination of 2 oral antibiotics, in addition to mupirocin nasal ointment and disinfectant soap, for at least 7 days.

AB - - The 'Stichting Werkgroep Antibioticabeleid' (SWAB; Dutch Working Party on Antibiotics Policy) has developed evidence-based guidelines for the antimicrobial treatment of methicillin-resistant Staphylococcus aureus (MRSA) carriers for the eradication of MRSA. - A distinction was made between uncomplicated and complicated carriage depending on the presence or absence of an active MRSA infection, skin lesions, foreign body material, mupirocin resistance and/or extranasal carriage. - The indication for treatment is determined by the consequences of carriage for the carrier and his/her environment, the adverse events of treatment, and the likelihood of a successful treatment. - The first choice of treatment in uncomplicated carriers is a combination of mupirocin nasal ointment and disinfectant soap for 5 days, along with hygiene advice. - If treatment fails, sources in the vicinity of the patient must be sought. - Complicated carriers receive a combination of 2 oral antibiotics, in addition to mupirocin nasal ointment and disinfectant soap, for at least 7 days.

UR - http://www.scopus.com/inward/record.url?scp=57649171387&partnerID=8YFLogxK

M3 - Review article

C2 - 19137966

SN - 0028-2162

VL - 152

SP - 2667

EP - 2671

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

IS - 49

ER -

Optimaliseren van het antibioticabeleid in Nederland. XII. SWAB-richtlijn voor de behandeling van MRSA-dragerschap

Abstract

Other files and links

Fingerprint

Cite this